‘We’re now in a golden age’: Professor Stephen Nicholls’ big takeaway from the American College of Cardiology conference
Professor Nicholls says there has been a 'proliferation of injectable therapies' for cardiometabolic disease prevention.
Last week, the American College of Cardiology’s Annual Scientific Sessions 2024 was held in Atlanta, Georgia.
Thousands of cardiologists and academics were in attendance, including Professor Stephen Nicholls, President of the Cardiac Society of Australia and New Zealand.
Professor Nicholls speaks to Cardiology Update about his research in lipid-lowering therapies, the future role of injectables in cardiovascular disease management, and the latest study findings that can be implemented in clinical practice without delay.
Cardiology Update: What were some highlights from this year’s conference?
